About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 5806351, 11 pages
https://doi.org/10.1155/2017/5806351
Research Article

Reduced Need for Rescue Antiemetics and Improved Capacity to Eat in Patients Receiving Acupuncture Compared to Patients Receiving Sham Acupuncture or Standard Care during Radiotherapy

1Division of Physiotherapy, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
2Department of Clinical Neuroscience, Osher Center for Integrative Medicine, Karolinska Institutet, Stockholm, Sweden
3Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
4Division of Clinical Cancer Epidemiology, Department of Oncology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden
5Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
6Division of Nursing, Department of Oncology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

Correspondence should be addressed to Anna Enblom

Received 4 October 2016; Accepted 10 January 2017; Published 8 February 2017

Academic Editor: Oliver Micke

Copyright © 2017 Anna Enblom et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. To evaluate if consumption of emesis-related care and eating capacity differed between patients receiving verum acupuncture, sham acupuncture, or standard care only during radiotherapy. Methods. Patients were randomized to verum () or sham () acupuncture (telescopic blunt sham needle) (median 12 sessions) and registered daily their consumption of antiemetics and eating capacity. A standard care group () received standard care only and delivered these data once. Results. More patients in the verum ( of 89 patients still undergoing radiotherapy; 82%, Relative Risk (RR) 1.23, 95% Confidence Interval (CI) 1.01–1.50) and the sham acupuncture group ( of 95; 83%, RR 1.24, CI 1.03–1.52) did not need any antiemetic medications, as compared to the standard care group ( out of 63; 67%) after receiving 27 Gray dose of radiotherapy. More patients in the verum ( of 89; 56%, RR 1.78, CI 1.31–2.42) and the sham acupuncture group ( of 94 answering patients; 62%, RR 1.83, CI 1.20–2.80) were capable of eating as usual, compared to the standard care group ( of 63; 39%). Conclusion. Patients receiving acupuncture had lower consumption of antiemetics and better eating capacity than patients receiving standard antiemetic care, plausible by nonspecific effects of the extra care during acupuncture.

1. Introduction

Many patients are interested in receiving acupuncture for a variety of symptoms during various types of cancer therapy [1], so also during radiotherapy [2], for example, emesis (nausea and vomiting) [3]. Acupuncture was seen to reduce emesis during radiotherapy [4] and chemotherapy [5] compared to standard care and in some studies also compared to sham acupuncture [5], but it is not known if acupuncture for emesis decreases consumption of emesis-related care and reduces negative consequences of emesis, for example, reduced eating capacity. Approximately 60–70 percent of patients were seen to experience nausea during abdominal or pelvic irradiation [3, 6]. If inadequately controlled, severe emesis may have clinical consequences, such as dehydration, electrolyte imbalance, and malnutrition. Care related to emesis thus includes, for example, intravenous nutrition in patients with reduced eating capacity, rescue antiemetic medications, need for sick transportations or hospitalising [7]. During chemotherapy, nausea was seen to have a negative impact on nutritional status [8]. In our previous study, we found that eating capacity was reduced in patients experiencing nausea during radiotherapy, compared to patients free from nausea [9]. It is well-known that the consumption of antiemetics and emesis-related care during chemotherapy is high and costly [10, 11]. In a study including 11,495 American outpatients receiving chemotherapy, the average emesis-related cost was 1855 US Dollars per patient and day with emesis [11]. According to our literature searches, there are no previous studies regarding consumption of emesis-related care during radiotherapy.

During fractioned radiotherapy, nausea may continue for several weeks and the long-term use of antiemetics may induce side-effects such as headache and constipation [6]. Antiemetics do not have satisfactory effects in all patients or are underused; in our previous study, one-third of patients with radiotherapy-induced nausea considered their antiemetic pharmacotherapy insufficient and three-quarters of the patients were interested in receiving acupuncture or in receiving more information regarding acupuncture for emesis [3]. There are indications that acupuncture in general compared to standard care may be a cost-effective therapy in a variety of other conditions [12], since the consumption of extra care decreased. Patients treated with verum acupuncture did not experience less emesis compared to patients treated with sham acupuncture [13], but acupuncture highly reduced emesis compared to standard care [4]. Even before the patient defines discomfort in the stomach area as nausea, the appetite and thus capacity to eat may decrease; it is not known if acupuncture affect patients’ eating capacity. In contrast to the large number of studies describing consequences of chemotherapy-induced emesis [8, 10, 11], emesis-related care-consumption and eating capacity during radiotherapy is to our knowledge not previously described. The purpose was thus to evaluate if consumption of emesis-related care and eating capacity differed between patients receiving verum acupuncture, sham acupuncture, or standard care only for emesis during radiotherapy.

2. Material and Methods

2.1. Design

The study was approved by the regional ethics committee (02-420, M167-04) and by an external monitoring committee and had two parts. The first part cross-sectionally after a mean dose of 27 Gray (Gy) compared patients randomized to verum or sham acupuncture (the “needling groups”) and patients receiving standard care (the “standard care group”) regarding emesis-related care, that is, consumption of antiemetics and eating capacity. The second part longitudinally compared patients randomized to verum and sham acupuncture regarding consumption of emesis-related care, that is, consumption of antiemetics, hospitalisation, stays at patient hotels or sick transportations, and eating capacity.

2.2. Patients and Setting

For the needling groups, we consecutively included patients at two Swedish University Hospitals during a three-year period (Figure 1). Inclusion criteria were an age of at least 18 years, a gynecologic, anal, rectal, colon, stomach, pancreatic, or testicular cancer, and a planned radiation over pelvic or abdominal fields of at least 800 cm3 volume and 25 Gy dose. Only patients with ability to give informed consent, and capability to take part in the treatment and data collection procedure were included, meaning that patients with very poor physical or mental condition were not included, for example, patients severely sedated and confused due to their cancer illness or mental illness. Exclusion criteria were antiemetic treatment or persistent emesis within 24 hours before start of radiotherapy (e.g., patients with constant emesis related to a vestibular neuritis were excluded, but not patients experiencing intermittent motion illness) or acupuncture therapy during the past year irrespective of indication or acupuncture therapy any time before for emesis. For the standard care group, we cross-sectionally during four different days included all patients receiving radiotherapy at one of the above mentioned University Hospitals, and also in another University Hospital, using the inclusion criteria mentioned above.

Figure 1: Number of patients included in the verum and sham acupuncture treatments and the data collection. The patients provided summed numbers of 10219 answers regarding antiemetic consumption and 10218 answers regarding eating capacity.

We screened 522 and 476 patients for participation in the needling groups and the standard care group, 169 and 363 did not meet study criteria, 138 and 50 did not want to participate, and 215 and 63 patients were originally included. Of these 215 patients, 15 did not participate, while 200 patients participated in the needling groups. At the time for the cross-sectional comparison after receiving mean 27 Gy, 184 out of the 200 patients were still undergoing radiotherapy (89 in the verum and 95 in the sham acupuncture group) (Figure 1), while 16 patients had finished radiotherapy due to the individual length of the therapy. One out of the 95 patients in the sham acupuncture group did not deliver data regarding eating capacity while all 89 and 63 patients in the verum acupuncture group and standard care group delivered data.

2.3. Procedure

Patients received fractioned radiotherapy, one fraction per day (Mondays to Fridays) for a median of five weeks. The patients were mostly treated as outpatients. If needed because of their cancer, medical condition, or severe side-effects, for example, emesis, they were treated as inpatients according to the ordinary clinical routines. The outpatients travelled to the radiotherapy department (a distance between 0 and 290 kilometres) by bus or car. If needed due to their medical condition, they used sick transportation. If the outpatients could not travel daily, they stayed at patient hotels.

The patients in the needling groups were informed orally and in written form that the beneficial effect of either treatment was not known and that “You will receive—without being told which—an ordinary acupuncture treatment with needles penetrating the skin or another treatment with needles placed just against the skin.” None of the randomization alternatives were cited as a “sham” or “placebo” treatment. A coordinating nurse, not involved in the needling, randomized the blinded patients stratified for gender and hospital to verum or sham acupuncture by using a computer-based randomization table. The evaluator (first author) and all healthcare professionals other than the acupuncture-providing therapists were blind to the treatment allocation. The standard care group knew, of course, that no acupuncture was given. They had been informed that the aim of the data collection was to investigate emesis during radiotherapy and its potential consequences.

2.4. The Healthcare Professionals and Care Routines

Oncologists not involved in the study prescribed rescue antiemetics if needed in both the needling groups and the standard care group, as suggested in international guidelines [14]. They prescribed antiemetics according to standardised ordinary clinical routines, at doses based on the Swedish Medicine Engine Information (http://www.fass.se) (Table 1). Oncology nurses identified potential need for extra care related to emesis, for example, the need for intravenous nutrition, according to ordinary clinical routines. In the needling groups, seven physiotherapists performed verum or sham acupuncture according to a standardised protocol. They started 30 minutes verum or sham acupuncture treatments the first day of radiotherapy and continued three times/week for the first two weeks, followed by twice/week for the remaining radiotherapy period (Mondays through Fridays), in line with suggested clinical routines to obtain long-term effects [15]. The physiotherapists were educated and experienced in the methods for practicing verum and sham acupuncture. They maintained everyday conversations with the patients but avoided the subject emesis. One to three patients were treated simultaneously in different rooms. For detailed information regarding the physiotherapists’ education and previous experiences of practicing acupuncture, please see our previous report [13].

Table 1: Routines for antiemetic prescriptions.
2.5. The Needling Groups

The physiotherapists delivered western medical manual verum acupuncture bilaterally to the standard antiemetic point pericardium six (PC6) [16] between the tendons of palmaris longus and flexor carpi radialis at two body-inches (one body-inch = one cun: the acupuncture-specific dimension equivalent to the greatest width of the individual patients’ thumb, approximately 1.5 cm) proximal to the wrist. Sharp needles in stainless steel (manufactured by DongBang, Korea), diameter 0.25 length 40 millimeters, were inserted to a depth of a half body-inch. The physiotherapists manipulated the needles three times (at the start, middle, and end of every session) by twirling and lifting until “deqi” occurred. “Deqi” was reached when the patient reported a sense of numbness or soreness and the physiotherapist noted a minimal muscular contraction around the needle [13].

The physiotherapists delivered sham acupuncture bilaterally to a nonacupuncture point two body-inches proximal to PC6 with the nonpenetrating telescopic sham needle “Park’s sham device” [17], 0.25 40 millimeters (fully extended length). The credible [18, 19] sham acupuncture needle (stainless steel, manufactured by DongBang, Korea) looks identical to a real needle but is blunted and glides upwards into its handle instead of penetrating, giving an illusion of penetration. “Park’s sham devise” marking tube with a bottom plate covered with double-sticky tape marked the needling-points in both groups, and holds the sham needle in place. The therapist manipulated the sham needles a few seconds three times per session resulting in that the needles touched the skin, but no “deqi” occurred [20]. Except for placing and manipulating the needle, the sham needle was not pressed against the skin at all (i.e., no “acupressure”) [16].

2.6. Data Collection

We in both the needling groups and the standard care group collected data on gender, age, tumor diagnosis, and dose of radiotherapy in the medical records, and the patients provided sociodemographic data and the data described below, using study-specific questions. The questions were developed from patient interviews, were tested for validity and reliability and were used in a pilot study [21]. This methodology of developing and validating study-specific questions [22] has been used in over 80 publications [2224].

2.6.1. Measurement of Emesis-Related Care

The patients in the needling groups every morning during the entire radiotherapy period (Mondays to Sundays) in writing answered the questions: “Have you within the previous 24 hours experienced nausea?” (“Yes” or “No”) and “Have you within the previous 24 hours been taking any medications for emesis (on prescription or without prescription)?” (“Yes” or “No”). The patients detailed the names and doses of the medications taken. The patients in the standard care group answered the same questions at the cross-sectional data collection.

The day after the last radiotherapy fraction had been given, only the patients in the needling groups answered also the written questions: “Have you any time within the radiotherapy period due to nausea or vomiting…: “…been hospitalised?”, “…choose to stay in the patient hotel instead of your usual living?”, and “…needed sick transportation (with taxi) to or from the radiotherapy department?” The patients answered the questions by “No” or “Yes, for the specific dates…” (the actual dates were specified).

2.6.2. Measurement of Eating Capacity

The patients in the needling groups every seventh morning during the entire radiotherapy period answered the question: “Have you been capable of eating as much as you are used to?” using the answering alternatives: “Yes,” “Yes, I have been eating more,” “No, I have been eating less,” “No, I have been eating much less,” or “No, I have been eating much less; I needed intravenous nutrition.” If the patients choose the last alternative, they also detailed the number of days with intravenous nutrition. The patients in the standard care group answered the same question at the cross-sectional data collection, using the two answering alternatives “Yes” or “No, I have been eating less.”

2.7. Statistical Analyses

We compared the verum and sham acupuncture group and the standard care group regarding the clinical and sociodemographic variables seen in Table 2. Chi-square test (nominal variables with more than five per category) or Fisher’s exact test (diagnosis), Mann-Whitney test regarding ordinal variables ( of previous nausea situations), and Student’s -test regarding continuous variables (age) were used.

Table 2: Clinical characteristics of the patients in the verum acupuncture, sham acupuncture, or standard care group.

After the patients had received a mean () radiotherapy dose of 27 Gy, we cross-sectionally compared the number () and proportion (%) of patients who experienced nausea and who used any type of antiemetic medication within the past 24 hours in the needling groups and the standard care group using Fisher’s exact test, presented as Relative Risks (RR) with 95 percent Confidence Intervals (CI). We cross-sectionally compared eating capacity between the groups (two-group comparison) using Mann-Whitney test.

In the needling groups only, we calculated and percent who used different types of antiemetic medications at least once within the longitudinal radiotherapy period and compared the verum and sham group using Fisher’s exact test, presented with RR and CI. If a difference occurred, we then compared the needling groups regarding number of days consuming the antiemetic medication (continuous but not normally distributed variables) with Mann-Whitney test. We calculated of patients and of days with need for hospitalisation, stays at patient hotels, or sick transportations due to emesis.

Eating capacity in the verum and sham acupuncture group was compared using Mann-Whitney test. Median number of days that the patients in the needling groups had been eating as usual, less, and much less during the entire radiotherapy period was calculated, and Chi-square test compared the verum and the sham acupuncture group regarding proportion of patients who at least once answered that he/she had been eating much less and needed intravenous nutrition. In the needling groups (verum and sham acupuncture group), the Wilcoxon sign test (paired samples, ordinal variable) compared the capacity to eat between the start and the end of radiotherapy, and between the end of radiotherapy and four weeks after radiotherapy, respectively. The Statistical Package for the Social Sciences for Windows version 23.0 was used. The significance level was set at 5 percent; values of 0.05 were considered as not statistically significant (ns).

3. Results

3.1. Patient Characteristics

Most patients in both the needling groups and the standard care group were women, at an age of more than 60 years, who received radiotherapy for a gynecological tumor (Table 2). There were no differences in sociodemographic or clinical variables between the verum acupuncture group, the sham acupuncture group, and the standard care group, except for the fact that the standard care group comprised more patients with a testicular tumor and thus more men than the needling groups. The patients in the needle groups were successfully blinded, as presented previously [13].

3.2. Consumption of Emesis-Related Care: Antiemetics

At the cross-sectional comparison after receiving mean 27 Gy, more patients in both the verum and sham acupuncture group were free from nausea (67 of 89; 75% and 77 of 95; 81%) and did not consume any antiemetic medication ( out of 89; 82% (RR 1.23, CI 1.01–1.50) and 79 out of 95; 83% (RR 1.23, CI 1.01–1.50)), as compared to the standard care group ( out of 63; 68%). The verum and the sham acupuncture group did not statistically differ regarding consumption of antiemetics (RR 1.01, CI 0.88–1.16) (Figure 2).

Figure 2: Proportion (%) of patients consuming antiemetics or not (left) and with capacity to eat as usual or not (right). Measured in patients in the verum acupuncture group; , sham acupuncture group; ( graded eating capacity), and standard care group; , when all three groups had received 27 Gray (mean) dose of radiotherapy.

According to the longitudinal analyses, 58 out of 100 (58%) patients in the verum acupuncture group and 63 out of 100 (63%) patients in the sham acupuncture group did not need to consume any antiemetic medication within the entire radiotherapy period (ns). More patients in the verum acupuncture group (87 of 100; 87%) than in the sham acupuncture group (75 of 100; 75%, RR 1.16, CI 1.01–1.33) did not consume corticosteroids. However, as presented in Table 3, number of days with consumption did not differ ().

Table 3: Consumption of medications for emesis in patients treated with verum acupuncture, sham acupuncture, or standard care during radiotherapy.
3.3. Consumption of Emesis-Related Care: Hospitalising and Sick Transportations

Hospitalising related to emesis was needed in two patients in the verum acupuncture group (for 1 and 8 days, resp.) and in two patients in the sham acupuncture group (for 1 and 16 days, resp.). Four patients in the verum acupuncture group and three in the sham group stayed at the patient hotel instead of in their ordinary dwelling at any time within the radiotherapy period due to emesis (range 5–44 days and 1–32 days). Three patients in both the verum (for one day each) and in the sham (range 2–8 days) acupuncture group needed sick transportation due to nausea.

3.4. Eating Capacity

At the cross-sectional comparison, more patients in both the verum ( out of 89; 56%; RR 1.78, CI 1.31–2.42) and the sham acupuncture group ( out of 94; 62%; RR 1.83, CI 1.20–2.80) were capable of eating as usual, as compared to the standard care group ( out of 63; 39%). The verum and the sham acupuncture groups did not statistically differ (RR 1.12, CI 0.83–1.50) (Figure 2).

At the start of radiotherapy, 136 of 195 (70%) answering patients in the needling groups were capable of eating as usual. The capacity to eat decreased with time (); at the end of the radiotherapy period 74 of 147 answering patients (50%) were capable of eating as usual. Eating capacity improved with time after the end of radiotherapy (); four weeks after the end 88 of 135 answering patients (65%) were capable of eating as usual. As presented in Figure 3, there were no differences in gradings of eating capacity between the verum and sham acupuncture groups. In the verum group () and the sham group (), 40 (40%) and 40 (40%) had at least at one time-point been eating much less, and 9 (9%) and 6 (6%) had been eating much less and did need intravenous nutrition (RR 1.50, CI 0.55–4.06). The number of days with various capacity to eat is presented in Table 4.

Table 4: Eating capacity in patients treated with verum or sham acupuncture during radiotherapy.
Figure 3: Proportion (%) of patients with different levels of eating capacity during and after radiotherapy in the verum and the sham acupuncture group. The number of patients decreases over time due to the individual length of radiotherapy. patients did not answer; reason unknown.

4. Discussion

This study found that patients receiving verum or sham acupuncture had lower consumption of antiemetics and better eating capacity than patients receiving standard antiemetic care only. The capacity to eat decreased during the radiotherapy period without differences between verum and sham acupuncture treated patients. Emesis-related care, other than antiemetic medications, was rarely needed.

Our findings may be interpreted as if the nonspecific components, including placebo-effects, of the needling procedure were effective to reduce the need for antiemetics in patients treated with radiotherapy while the specific characteristics of verum acupuncture were not effective. Specific components of genuine acupuncture may be penetration and stimulation of the skin at traditional acupuncture points [16]. Most medical treatments include components that may be divided into a specific treatment component, for example, a pharmacological substance, and a nonspecific component that includes the context surrounding the delivery of treatment [25]. The nonspecific treatment component is typically conveyed via the patient-clinician interaction and the context for treatment [26]. Our verum and sham acupuncture treated patients received extra care in terms of contact with a physiotherapist during needling, although the physiotherapist often treated two to three patients simultaneously, and the patients rested and often relaxed during the needling sessions. A wide range of studies of placebo treatments have elucidated pathways through which placebo-effects can be activated, often described as an interaction between psychological processes (e.g., expectations, hope) and neurobiological mechanisms (e.g., endocrine and immune functions) [27, 28]. Both the verum and the sham acupuncture group strongly believed that they received a genuine effective treatment, while the standard care group received no extra treatment and thus probably had lower expectations to stay unaffected from nausea and to be capable of eating as usual. High expectations, in terms of belief in the efficacy of acupuncture on the treated outcome, highly modified the effect in previous acupuncture interventions in a variety of settings [29]. That the verum and sham acupuncture groups were compared with a cross-sectional standard care group in our study, not to a third randomized arm, required for a thorough investigation of potential imbalance of confounding factors between the groups. Only testicular tumor patients and thus men were more frequent in the standard care group than in the needling groups. However, actually male gender reduces the risk for radiotherapy-induced emesis [3, 6]. The design may have the benefit of avoiding the impact of the patient information or the data collection per se on reported outcomes. Expectations to receive or not to receive an effective treatment [26, 29], as well as repeated measurement of outcomes per se, may reduce (through the so called Hawthorne effect) or increase emesis experience.

In this study, we evaluated if manual western acupuncture of the frequently used antiemetic point PC6 [16] reduced consumption of emesis-related care. Every condition treated with a certain type of acupuncture needs its own evaluation, and based on findings from our study we are unable to predict the effects of other kinds of acupuncture such as electroacupuncture or using more seldom used [16] antiemetic acupuncture points. In previous studies, manual acupuncture did not reduce nausea more than sham using a telescopic nonpenetrating needle, during neither chemotherapy () [30] nor radiotherapy () [4]. For chemotherapy-induced nausea, electroacupuncture of the point K1 on the heel did not reduce nausea or vomiting more than electroacupuncture on a sham-point () [31]. However, K1 is not a traditional antiemetic point [16]. Electroacupuncture of PC6 reduced vomiting more than either simulated electroacupuncture with superficially inserted needles or standard care () [5]. However, data indicate that the blinding of the patients may have failed. During chemotherapy, manual () [32] or electroacupressure () [33] and manual acupressure combined with manual acupuncture () [34] both failed to reduce nausea more than a simulation of electroacupressure. However, manual acupressure () reduced nausea and vomiting more than both sham-points and standard care [35]. Chemotherapy patients () [36] and radiotherapy patients () [4] receiving acupuncture experienced less nausea compared to patients receiving standard care, including antiemetics alone. Chemotherapy patients () [37] and () [38], and radiotherapy patients () [39] receiving acupressure, and chemotherapy patients () receiving combined acupuncture and acupressure [40], all had larger reductions of nausea compared to patients receiving standard care. Accordingly, the results of different studies vary a lot and indicate large nonspecific effects. In a recent study regarding relaxing effects of acupuncture (), individuals who received positive communication regarding expected treatment effects doubled their treatment expectations as compared to individuals receiving neutral communication and the individuals with high expectation doubled the improvement in relaxation as compared to individuals with low expectations [41]. Irrespective of the fact that if the benefit for the patients was based on nonspecific or specific effects of acupuncture, the needling seemed beneficial for the patients. This is in line with results regarding acupuncture in general; a review of acupuncture for various pain conditions, indicate benefit for patients but larger nonspecific than specific effects of acupuncture [42].

The fact that more patients in both the verum and the sham acupuncture group were capable of eating as usual, as compared to the standard care group, is a new observation. According to our literature search (https://www.pubmed.gov, search terms radiotherapy and nutrition, or radiotherapy and eating, date 1st September 2016), there are no previous studies describing eating capacity in cancer patients irradiated over abdominal or pelvic fields. The better eating capacity seen in the needling groups was probably valuable for the patients; only 66 percent of nauseous patients were able to eat as usual during radiotherapy as compared to 84 percent of patients free from nausea in a previous study [9]. Regarding the more studied chemotherapy-induced nausea, Farrell and coworkers [8] in 104 patients observed that severe nausea had a negative impact on nutritional status. Improved eating capacity and thus nutrition status seems very beneficial for patients undergoing emetogenic cancer therapy [7].

The need for hospitalising, stays in patient hotels, and sick transportations related to emesis was low in patients treated with both verum and sham acupuncture, probably due to the fact that radiotherapy-induced nausea often is of low intensity. In previous studies, the intensity of radiotherapy-induced nausea was graded as mild in 60 to 72 percent of nauseous patients [3, 4, 13]. Although the long-term nausea during radiotherapy is bothersome for the patients in terms of reduced quality of life [3, 9], mild nausea possibly less often causes need of extra care, in contrast to chemotherapy-induced nausea [10, 11]. That the consumption of emesis-related care did not differ between the verum and sham acupuncture group may be interpreted as that verum acupuncture does not affect consumption of emesis-related care during radiotherapy, or that a “floor-effect” was seen. We do not know if the need for hospitalising, stays in patient hotels, and sick transportations related to emesis would have been higher if no needling had been given, since we did not collect these data in the cross-sectional standard care group.

Strengths of the study are not only the high compliance with data collection and the thorough control of reasons for cancellations of therapy and of potential imbalance between the needling groups and the standard care group, but also the large number of studied patients as compared to many other studies on emesis [16]. Without the thorough control of potential imbalance between the needling groups and the standard care cohort, a weakness of our study would have been the cross-sectionally performed comparisons. When interpreting the results of an acupuncture study, it is important to take the reasons for cancelling into consideration. Hypothetically, some patients in the sham acupuncture group could have cancelled because of occurrence of emesis leading to hospitalising, whereas patients in the verum acupuncture group could have cancelled because of lack of emesis (the patients may find it unnecessary with further needling) leading to the lack of difference between the groups. However, this was not true in our study, since cancelling were related to other factors than emesis. At the data collection at the end of radiotherapy, 15 patients in the verum and 18 patients in the sham acupuncture group did not deliver data. It accordingly seemed more difficult for the patients to comply with data collection when they did no longer had contact with the needling therapist and the study coordinator. Other strengths of the study are the sham-controlled design using the nonpenetrating sham needle which is as both credible and inert as possible [19]. Of course the telescopic sham needle touched the skin during the few seconds for placing and manipulating the sham needles every needling session. However, the sensorimotor activation of a variety of brain regions was clearly lower during sham needling as compared to during verum acupuncture needling [20]. We choose to measure care-consumption and eating capacity using pretested [21] and previously used [9] single item questions, adopting a methodology [22] developing questions those patients find meaningful and not too bothering [24]. The choice of using single questions was based on a wish to reduce the patient burden compared to a longer psychometric questionnaire, which seemed important since some of the questions were repeated daily. The eating capacity question seemed to be enough sensitive, since it in a previous study discriminated between patients with and without nausea [21]. We made no power-calculation for the outcomes emesis-related care-consumption and eating capacity. However, the study met the preformed criteria for statistical power regarding the primary endpoint that our previous main study [13] was primary designed for; occurrence of nausea ( patients, effect size 20%, 80% power at 5% significance level).

Since nonspecific antiemetic treatment effects during the needling caring situation seem to have achieved the fact that both patients receiving verum and sham acupuncture needed less antiemetics and had larger capacity to eat compared to patients receiving standard care, further studies should evaluate the effect of contextual caring factors for strengthening the quality of care and reducing side-effects such as emesis during cancer therapy.

Competing Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors are thankful to the participating patients, to Boel Lindberg and Ingrid Tillgren for coordinating, to Anna Johnsson, Marianne Frid, Annica Tomasson, Clary Skoglund, Eva Ahlner, and Lotta Robert for acupuncture treatments, to the healthcare professionals at the radiotherapy departments for cooperation, to Erik Onelöv for statistical support, and to professor Mats Lekander for valuable advises. This study was supported by the Swedish Cancer Society, the Region of Östergötland, the University of Linköping, the Cancer Rehabilitation Foundation, the Swedish Institute of Health Research, the Vårdal Foundation for Healthcare Sciences and Allergy Research, and the Osher Center for Integrative Research, Karolinska Institutet, Sweden.

References

  1. A. Molassiotis, P. Fernandez-Ortega, D. Pud et al., “Use of complementary and alternative medicine in cancer patients: a European survey,” Annals of Oncology, vol. 16, no. 4, pp. 655–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. B. Swarup, W. Barrett, and A. R. Jazieh, “The use of complementary and alternative medicine by cancer patients undergoing radiation therapy,” American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 29, no. 5, pp. 468–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Enblom, B. Bergius Axelsson, G. Steineck, M. Hammar, and S. Börjeson, “One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient,” Supportive Care in Cancer, vol. 17, no. 1, pp. 23–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Enblom, M. Lekander, M. Hammar et al., “Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care,” PLoS ONE, vol. 6, no. 3, Article ID e14766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Shen, N. Wenger, J. Glaspy et al., “Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial,” Journal of the American Medical Association, vol. 284, no. 21, pp. 2755–2761, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Feyer, F. Jahn, and K. Jordan, “Radiation induced nausea and vomiting,” European Journal of Pharmacology, vol. 722, no. 1, pp. 165–171, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Krishnasamy, W. Kwok-Wei So, P. Yates et al., “The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey,” Cancer Nursing, vol. 37, no. 4, pp. E27–E35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Farrell, S. G. Brearley, M. Pilling, and A. Molassiotis, “The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life,” Supportive Care in Cancer, vol. 21, no. 1, pp. 59–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Enblom, G. Steineck, and S. Börjeson, “Emesis and gastrointestinal problems during radiotherapy: a comparison of performance of daily activities between patients experiencing nausea and patients free from nausea,” European Journal of Oncology Nursing, vol. 14, no. 5, pp. 359–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Carlotto, V. L. Hogsett, E. M. Maiorini, J. G. Razulis, and S. T. Sonis, “The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue,” PharmacoEconomics, vol. 31, no. 9, pp. 753–766, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Craver, J. Gayle, S. Balu, and D. Buchner, “Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States,” Journal of Medical Economics, vol. 14, no. 1, pp. 87–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-Y. Kim, H. Lee, Y. Chae, H.-J. Park, and H. Lee, “A systematic review of cost-effectiveness analyses alongside randomised controlled trials of acupuncture,” Acupuncture in Medicine, vol. 30, no. 4, pp. 273–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Enblom, A. Johnsson, M. Hammar, E. Onelöv, G. Steineck, and S. Börjeson, “Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea—a randomized controlled study,” Annals of Oncology, vol. 23, no. 5, pp. 1353–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Ruhlmann, F. Jahn, K. Jordan, et al., “2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting,” Supportive Care in Cancer, vol. 25, no. 1, pp. 309–316, 2017. View at Publisher · View at Google Scholar
  15. C. Carlsson, “Acupuncture mechanisms for clinically relevant long-term effects—reconsideration and a hypothesis,” Acupuncture in Medicine, vol. 20, no. 2-3, pp. 82–99, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Ezzo, M. A. Richardson, A. Vickers et al., “Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting,” The Cochrane Database of Systematic Reviews, no. 2, Article ID CD002285, 2006. View at Google Scholar · View at Scopus
  17. J. Park, A. White, H. Lee, and E. Ernst, “Development of a new sham needle,” Acupuncture in Medicine, vol. 17, no. 2, pp. 110–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Enblom, A. Johnsson, M. Hammar, G. Steineck, and S. Börjeson, “The nonpenetrating telescopic sham needle may blind patients with different characteristics and experiences when treated by several therapists,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 185034, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. S. Zhang, H. Y. Tan, G. S. Zhang, A. L. Zhang, C. C. Xue, and Y. M. Xie, “Placebo devices as effective control methods in acupuncture clinical trials: a systematic review,” PLoS ONE, vol. 10, no. 11, Article ID e0140825, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Lai, G. Zhang, Y. Huang et al., “A cerebral functional imaging study by positron emission tomography in healthy volunteers receiving true or sham acupuncture needling,” Neuroscience Letters, vol. 452, no. 2, pp. 194–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Enblom, A. Tomasson, M. Hammar, G. Steineck, and S. Börjeson, “Pilot testing of methods for evaluation of acupuncture for emesis during radiotherapy: a randomised single subject experimental design,” Acupuncture in Medicine, vol. 29, no. 2, pp. 94–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Steineck, K. Bergmark, L. Henningsohn, M. Al-Abany, P. W. Dickman, and A. Helgason, “Symptom documentation in cancer survivors as a basis for therapy modifications,” Acta Oncologica, vol. 41, no. 3, pp. 244–252, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Kreicbergs, U. Valdimarsdóttir, P. G. Steineck, and J.-I. Henter, “A population-based nationwide study of parents' perceptions of a questionnaire on their child's death due to cancer,” The Lancet, vol. 364, no. 9436, pp. 787–789, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Dunberger, H. Thulin, A.-C. Waldenström et al., “Cancer survivors' perception of participation in a long-term follow-up study,” Journal of Medical Ethics, vol. 39, no. 1, pp. 41–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Colloca, L. Lopiano, M. Lanotte, and F. Benedetti, “Overt versus covert treatment for pain, anxiety, and Parkinson's disease,” The Lancet Neurology, vol. 3, no. 11, pp. 679–684, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Enck, U. Bingel, M. Schedlowski, and W. Rief, “The placebo response in medicine: minimize, maximize or personalize?” Nature Reviews Drug Discovery, vol. 12, no. 3, pp. 191–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Benedetti and M. Amanzio, “Mechanisms of the placebo response,” Pulmonary Pharmacology & Therapeutics, vol. 26, no. 5, pp. 520–523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Albring, L. Wendt, S. Benson et al., “Placebo effects on the immune response in humans: the role of learning and expectation,” PLOS ONE, vol. 7, no. 11, Article ID e49477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Colagiuri and C. A. Smith, “A systematic review of the effect of expectancy on treatment responses to acupuncture,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 857804, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Streitberger, M. Friedrich-Rust, H. Bardenheuer et al., “Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial,” Clinical Cancer Research, vol. 9, no. 7, pp. 2538–2544, 2003. View at Google Scholar · View at Scopus
  31. Y. Shen, L. Liu, J. S. Chiang et al., “Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea,” Cancer, vol. 121, no. 1, pp. 84–92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Molassiotis, W. Russell, J. Hughes et al., “The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial,” Health Technology Assessment, vol. 17, no. 26, pp. 1–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. Roscoe, S. E. Matteson, G. R. Morrow et al., “Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer,” Journal of Pain and Symptom Management, vol. 29, no. 4, pp. 376–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Melchart, A. Ihbe-Heffinger, B. Leps, C. Von Schilling, and K. Linde, “Acupuncture and acupressure for the prevention of chemotherapy-induced nausea—a randomised cross-over pilot study,” Supportive Care in Cancer, vol. 14, no. 8, pp. 878–882, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. L. Dibble, J. Luce, B. A. Cooper et al., “Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial,” Oncology Nursing Forum, vol. 34, no. 4, pp. 813–820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Rithirangsriroj, T. Manchana, and L. Akkayagorn, “Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients,” Gynecologic Oncology, vol. 136, no. 1, pp. 82–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. Roscoe, G. R. Morrow, J. T. Hickok et al., “The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting: a university of rochester cancer center community clinical oncology program multicenter study,” Journal of Pain and Symptom Management, vol. 26, no. 2, pp. 731–742, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. H. S. Avci, N. Ovayolu, and Ö. Ovayolu, “Effect of acupressure on nausea-vomiting in patients with acute myeloblastic leukemia,” Holistic Nursing Practice, vol. 30, no. 5, pp. 257–262, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. J. A. Roscoe, P. Bushunow, P. Jean-Pierre et al., “Acupressure bands are effective in reducing radiation therapy-related nausea,” Journal of Pain and Symptom Management, vol. 38, no. 3, pp. 381–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. S. Xia, J. H. Wang, and L. J. Shan, “Acupuncture plus ear-point press in preventing vomiting induced by chemotherapy with cisplatin,” International Journal of Clinical Acupuncture, vol. 11, pp. 145–148, 2000. View at Google Scholar
  41. A. Rosén, M. Lekander, K. Jensen et al., “Relaxing effects of acupuncture: genuine acupuncture effects or effects of the therapist's communication style?” in Proceedings of the Stockholm Stress Center Annual Workshop, abstract 2014#1, Stockholm, Sweden, 2014.
  42. A. J. Vickers, A. M. Cronin, A. C. Maschino, et al., “Acupuncture for chronic pain: individual patient data meta-analysis,” Archive of Internal Medicine, vol. 172, no. 19, pp. 1444–1453, 2012. View at Publisher · View at Google Scholar